Oyster Point Pharma, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 22.026 million compared to USD 15.494 million a year ago. Net loss was USD 22.016 million compared to USD 15.464 million a year ago. Basic loss per share from continuing operations was USD 0.85 compared to USD 0.66 a year ago. For the half year, operating loss was USD 40.946 million compared to USD 32.423 million a year ago. Net loss was USD 40.925 million compared to USD 31.983 million a year ago. Basic loss per share from continuing operations was USD 1.58 compared to USD 1.43 a year ago.